Health Care & Life Sciences » Pharmaceuticals | Miraca Holdings Inc.

Miraca Holdings Inc. | Ownership

Companies that own Miraca Holdings Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
International Value Advisers LLC
5,031,400
8.77%
737,900
1.47%
08/13/2018
Asset Management One Co., Ltd.
2,014,600
3.51%
-473,100
0.04%
08/15/2018
T. Rowe Price Associates, Inc.
1,968,100
3.43%
-129,100
0.01%
04/13/2018
BlackRock Fund Advisors
1,857,000
3.24%
224,500
0%
05/15/2018
T. Rowe Price International Ltd.
1,552,000
2.71%
-688,900
0.08%
04/13/2018
Nomura Asset Management Co., Ltd.
1,384,698
2.41%
-330,165
0.02%
07/31/2018
The Vanguard Group, Inc.
1,236,273
2.15%
-2,700
0%
07/31/2018
T. Rowe Price Japan, Inc.
994,600
1.73%
994,600
3%
04/13/2018
Norges Bank Investment Management
990,709
1.73%
-72,172
0%
12/31/2017
BlackRock Japan Co., Ltd.
895,400
1.56%
34,800
0.03%
05/15/2018

About Miraca Holdings

View Profile
Address
Shinjuku Mitsui Building, 8/F
Tokyo Tokyo 163
Japan
Employees -
Website http://www.miraca-holdings.co.jp
Updated 07/08/2019
Miraca Holdings Inc. operates as a holding company which provides the strategic planning, investor relations, public relations, and supervisory management of the entire group. It operates through the following segments: In Vitro Diagnostics, Clinical Laboratory Testing, and Healthcare Related. The In Vitro Diagnostic segment offers clinical laboratory testing services; collecting consigned specimens of patients from medical institutions, conducting analyses and reporting the test results back.